热点
"Lunsumio" 相关文章
CHMP recommends EU approval of Roche’s subcutaneous formulation of Lunsumio for people with relapsed or refractory follicular lymphoma
INVESTOR 2025-09-29T02:49:44.000000Z
CHMP recommends EU approval of Roche’s subcutaneous formulation of Lunsumio for people with relapsed or refractory follicular lymphoma
MEDIA 2025-09-29T02:49:25.000000Z